Observational studyDrug design, development and therapy2024

Effectiveness of the Use of the Human Recombinant Epidermal Growth Factor in the Subsidized Regime vs The Contributive Regime in Patients with Venous Ulcers in Bogotá.

Maria Teresa Cacua Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.